Kammer Robert J
Related Filers (1)
Ownership (40)
4
Monday, 6/28/2021
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/13/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/8/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/11/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/14/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/16/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/5/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/3/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/2/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 3/4/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 2/1/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/3/2019
HARROW HEALTH, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/6/2018
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/2/2018
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/18/2018
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/5/2018
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/15/2018
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/2/2018
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2017
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2017
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/14/2017
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2016
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 8/30/2016
Imprimis Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 6/14/2016
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 12/28/2015
Imprimis Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 5/15/2015
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/27/2015
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/2/2014
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/8/2014
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
5
Tuesday, 4/22/2014
Imprimis Pharmaceuticals, Inc.: Annual statement of changes in beneficial ownership of securities
SC 13D
Friday, 8/16/2013
Imprimis Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 7/1/2013
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
5
Friday, 3/15/2013
Imprimis Pharmaceuticals, Inc.: Annual statement of changes in beneficial ownership of securities
SC 13D
Friday, 8/10/2012
Imprimis Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 7/20/2012
Imprimis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/2/2012
Imprimis Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Monday, 4/30/2012
Imprimis Pharmaceuticals, Inc.: Major Shareholders
3
Monday, 4/30/2012
Imprimis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities